Purchase Order 75N90025P00541
Award Date
6/25/25
Potential Completion Date
7/24/25
Potential Value
$29K
Federal Agency
NIH Clinical Center
Awardee
10X Genomics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc. for the supply of 10X Genomics reagents. The contract has a ceiling value of $42,000.00 and a period of performance through September 30, 2024. 10X Genomics, a for-profit manufacturer, is the prime contractor and no set-aside designation was used. The contract supports the NIH's research efforts, specifically in the area of neurological diseases and disorders. The...
This firm fixed-price purchase order contract, valued at $56,335.89, was awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and bioinformatics software. The contract is to provide reagents needed for ongoing research by the Critical Care Medicine Department at the NIH. This contract is not set aside and is part of a larger indefinite delivery contract (IDC) valued up to $7,000,000...
This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc. for $79,075.50. The contract is for the provision of 10X Genomics' products and services, including specialized kits, instruments, and associated installation, training, maintenance, and support services, to support biomedical research efforts. The contract does not have a set-aside designation. As a prime contractor, 10X Genomics has an existing...
This is a $12,000 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a life sciences technology company headquartered in Pleasanton, California. The contract is not set aside and runs through July 2026. 10X Genomics will provide specialized scientific equipment, consumables, and research tools to support advanced biomedical research across various domains, including infectious diseases, cancer, neurological disorders, and...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health (NIH), to 10X Genomics, Inc. The contract, valued at $100,100.00, is for the provision of 10X Genomics' specialized genomics analysis products and services, including kits, instruments, and supporting services for single-cell and spatial analysis applications. The contract supports biomedical...
This is a firm fixed price delivery order contract awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a life sciences technology company that specializes in genomic analysis products and services. The $13,774.25 contract is for the provision of reagents needed for the Critical Care Medicine Department's research efforts. The contract does not have a set-aside designation and is a call against a Blanket Purchase Agreement (BPA) with an ultimate completion...
This firm fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences, a component of the National Institutes of Health within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $22,349.00 award is for the delivery of 10X Genomics' specialized kits, instruments, and associated services to support biomedical research activities. The contract does not have a set-aside designation. As a prime contractor, 10X Genomics has...
This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to 10X Genomics, Inc., a life sciences technology company based in Pleasanton, California. The $53,461.29 contract is for the supply of reagents needed for ongoing research by the NIH's Critical Care Medicine Department. The contract has no set-aside designation and is scheduled for completion by July 24, 2025. 10X Genomics is a major provider of advanced genomic analysis...
This is a $12,000 firm fixed price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract has an ultimate completion date of July 4, 2026 and is not set aside. 10X Genomics specializes in single-cell and spatial genomic analysis solutions that support...
This is a $19,248 firm fixed price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract, which has a completion date of January 24, 2026, does not have a set-aside designation. 10X Genomics is providing specialized scientific equipment,...